RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and automation company focused on improving the speed, safety, and scalability of oral fluid drug testing and beyond. The company enters the market with a leadership team of industry veterans and a clear commitment to addressing longstanding inefficiencies in pre-analytical workflows that have limited the adoption and reliability of oral fluid testing across clinical and forensic settings.

RICHMOND, Va. and RENO, Nev., Jan. 26, 2026 /PRNewswire/ -- Alps Dx and Hamilton Company today announced the showcase of Alps Dx Atelier, an automated system designed to streamline and standardize the preanalytical stage of oral fluid drug testing. This instrument will be showcased at the Alps Dx booth at the SLAS 2026 conference in Boston, Mass. Built on the Hamilton MICROLAB® STARlet liquid handling platform, Alps Dx Atelier integrates patented technologies, dedicated modules, consumables, and workflow software developed by Alps Dx specifically for oral fluid applications.